Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis

Abstract

MRI features of cerebral small vessel disease (CSVD), i.e. white matter hyperintensities, lacunes, microbleeds, perivascular spaces, and cerebral atrophy, may be associated with clinical events, but the strength of these associations remains unclear. We conducted a systematic review and meta-analysis on the association between these features and incident ischaemic and haemorrhagic stroke, all-cause dementia and depression, and all-cause mortality. For the association with stroke, 36 studies were identified (number of individuals/events [n] = 38,432/4,136), for dementia 28 (n = 16,458/1,709), for depression nine (n = 9,538/1,746), and for mortality 28 (n = 23,031/2,558). Only two studies evaluated perivascular spaces; these results were not pooled. Pooled analyses showed that all other features were associated with all outcomes (hazard ratios ranged 1.22-2.72). Combinations of two features were more strongly associated with stroke than any individual feature. Individual features and combinations of CSVD features are strongly associated with incident ischaemic and haemorrhagic stroke, all-cause dementia and depression, and all-cause mortality. If these associations are causal, the strength of these associations suggests that a substantial burden of disease is attributable to CSVD.

References 34

1. 1.

   Akoudad S, Portegies MLP, Koudstaal PJ, Hofman A, Van Der Lugt A, Ikram MA, Vernooij MW. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam study. Circulation. 2015;132:509-516.

   Not in our library10.1161/circulationaha.115.016261

2. 2.

   Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54:915-922.

   Not in our library10.1001/archpsyc.1997.01830220033006

3. 3.

   Barengo NC, Antikainen R, Kastarinen M, Laatikainen T, Tuomilehto J. The effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohort. J Hum Hypertens. 2013;27:693-697.

   Not in our library10.1038/jhh.2013.22

4. 4.

   Benjamin P, Zeestraten E, Lambert C, Ster IC, Williams OA, Lawrence AJ, Patel B, MacKinnon AD, Barrick TR, Markus HS. Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials. J Cereb Blood Flow Metab. 2016;36:228-240.

   Not in our library10.1038/jcbfm.2015.113

5. 5.

   Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet. 2011;377:108-109.

   Not in our library10.1016/s0140-6736(10)60903-8

6. 6.
   Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds · 2017

   No notice
7. 7.

   Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke. 2013;44:995-1001.

   Not in our library10.1161/strokeaha.111.000038

8. 8.

   Charidimou A, Shams S, Romero JR, Ding J, Veltkamp R, Horstmann S, Eiriksdottir G, van Buchem MA, Gudnason V, Himali JJ, Gurol ME, Viswanathan A, Imaizumi T, Vernooij MW, Seshadri S, Greenberg SM, Benavente OR, Launer LJ, Shoamanesh A, International MMI. Clinical significance of cerebral microbleeds on MRI: a comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1). Int J Stroke. 2018.

   Not in our library10.1177/1747493017751931

9. 9.

   De Guio F, Jouvent E, Biessels GJ, Black SE, Brayne C, Chen C, Cordonnier C, De Leeuw FE, Dichgans M, Doubal F, Duering M, Dufouil C, Duzel E, Fazekas F, Hachinski V, Ikram MA, Linn J, Matthews PM, Mazoyer B, Mok V, Norrving B, O’Brien JT, Pantoni L, Ropele S, Sachdev P, Schmidt R, Seshadri S, Smith EE, Sposato LA, Stephan B, Swartz RH, Tzourio C, van Buchem M, van der Lugt A, van Oostenbrugge R, Vernooij MW, Viswanathan A, Werring D, Wollenweber F, Wardlaw JM, Chabriat H. Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease. J Cereb Blood Flow Metab. 2016;36:1319-1337.

   Not in our library10.1177/0271678x16647396

10. 10.

    de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33:1152-1162.

    Not in our library10.1161/01.str.0000014421.15948.67

11. 11.

    Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.

    Not in our library10.1136/bmj.c3666

12. 12.

    Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C, Investigators, P.M.S. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril protection against recurrent stroke study) magnetic resonance imaging substudy. Circulation. 2005;112:1644-1650.

    Not in our library10.1161/circulationaha.104.501163

13. 13.

    Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463.

    Not in our library10.1111/j.0006-341x.2000.00455.x

14. 14.

    Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L. Trends in death rates among U.S. Adults with and without diabetes between 1997 and 2006: findings from the national health interview survey. Diabetes Care. 2012;35:1252-1257.

    Not in our library10.2337/dc11-1162

15. 15.

    Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States. N Engl J Med. 2014;370(1990–2010):1514-1523.

    Not in our library10.1056/nejmoa1310799

16. 16.

    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.

    Not in our library10.1002/sim.1186

17. 17.
    Accumulation of MRI Markers of Cerebral Small Vessel Disease is Associated with Decreased Cognitive Function. A Study in First-Ever Lacunar Stroke and Hypertensive Patients · 2013

    No notice
18. 18.

    Imano H, Kitamura A, Sato S, Kiyama M, Ohira T, Yamagishi K, Noda H, Tanigawa T, Iso H, Shimamoto T. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the circulatory risk in communities study (CIRCS). Stroke. 2009;40:1571-1577.

    Not in our library10.1161/strokeaha.108.538629

19. 19.

    Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, Sullivan M, Horowitz KR, Ding J, Marcovina S, Lovato LC, Lovato J, Margolis KL, O’Connor P, Lipkin EW, Hirsch J, Coker L, Maldjian J, Sunshine JL, Truwit C, Davatzikos C, Bryan RN, investigators, A.M. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969-977.

    Not in our library10.1016/s1474-4422(11)70188-0

20. 20.

    Li G, Rhew IC, Shofer JB, Kukull WA, Breitner JC, Peskind E, Bowen JD, McCormick W, Teri L, Crane PK, Larson EB. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007;55:1161-1167.

    Not in our library10.1111/j.1532-5415.2007.01233.x

21. 21.

    Ostergaard L, Engedal TS, Moreton F, Hansen MB, Wardlaw JM, Dalkara T, Markus HS, Muir KW. Cerebral small vessel disease: capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab. 2016;36:302-325.

    Not in our library10.1177/0271678x15606723

22. 22.

    Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701.

    Not in our library10.1016/s1474-4422(10)70104-6

23. 23.

    Prasad K, Wiryasaputra L, Ng A, Kandiah N. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer’s disease in a clinic cohort. Dement Geriatr Cogn Disord. 2011;31:431-434.

    Not in our library10.1159/000330019

24. 24.

    Puy L, De Guio F, Godin O, Duering M, Dichgans M, Chabriat H, Jouvent E. Cerebral microbleeds and the risk of incident ischemic stroke in CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). Stroke. 2017;48:2699-2703.

    Not in our library10.1161/strokeaha.117.017839

25. 25.

    Sharp SI, Aarsland D, Day S, Sonnesyn H, Ballard C, Syst, As.S.V.D. Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry. 2011;26:661-669.

    Not in our library10.1002/gps.2572

26. 26.

    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.

    Not in our library10.1001/jama.283.15.2008

27. 27.

    van Agtmaal MJM, Houben A, Pouwer F, Stehouwer CDA, Schram MT. Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis. JAMA Psychiatry. 2017.

    Not in our library10.1001/jamapsychiatry.2017.0984

28. 28.

    Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, Imai Y, Ohkubo T, Kario K. Short- and long-term incidence of stroke in white-coat hypertension. Hyperfine Interactions. 2005;45:203-208.

    Not in our library10.1161/01.hyp.0000151623.49780.89

29. 29.

    Wang DN, Hou XW, Yang BW, Lin Y, Shi JP, Wang N. Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:2728-2737.

    Not in our library10.1016/j.jstrokecerebrovasdis.2015.08.003

30. 30.

    Wang L, Leonards CO, Sterzer P, Ebinger M. White matter lesions and depression: a systematic review and meta-analysis. J Psychiatr Res. 2014;56:56-64.

    Not in our library10.1016/j.jpsychires.2014.05.005

31. 31.

    Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.

    Not in our library10.1016/s1474-4422(13)70124-8

32. 32.

    Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, Murray AM, Sullivan MD, Horowitz KR, Ding J, Marcovina S, Lovato L, Lovato J, Margolis KL, Davatzikos C, Barzilay J, Ginsberg HN, Linz PE, Miller ME, Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes, I. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med. 2014;174:324-333.

    Not in our library10.1001/jamainternmed.2013.13656

33. 33.

    Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology. 2004;63:1181-1186.

    Not in our library10.1212/01.wnl.0000140291.86406.d1

34. 34.

    Yu M, Zhang X, Lu F, Fang L. Depression and risk for diabetes: a meta-analysis. Can J Diabetes. 2015;39:266-272.

    Not in our library10.1016/j.jcjd.2014.11.006

Cited by papers we hold 5

• Nitrate Metabolism and Ischemic Cerebrovascular Disease: A Narrative Review · 2022
  Not checked
• Cerebral small vessel disease phenotype and 5-year mortality in asymptomatic middle-to-old aged individuals · 2021
  Not checked
• Cerebral Small‐Vessel Disease and Risk of Incidence of Depression: A Meta‐Analysis of Longitudinal Cohort Studies · 2020
  Not checked
• Mechanisms and treatment of late-life depression · 2019
  No notice
• Understanding depression in type 2 diabetes: a biological approach in observational studies [version 1; referees: 2 approved] · 2018
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.